Study of Surrogate Immunohistochemical Markers IDH1, ATRX, BRAF V600E, and p53 Mutation in Astrocytic and Oligodendroglial Tumors
Introduction In consonance with current the World Health Organization (WHO) classification of the central nervous system (CNS) tumors (2016), histological diagnosis of gliomas should be reinforced by molecular information. This study was performed to determine the frequency of isocitrate...
Main Authors: | Santosh Sharma, Kusum Mathur, Alka Mittal, Meel Mukta, Arpita Jindal, Mukesh Kumar |
---|---|
Format: | Article |
Language: | English |
Published: |
Thieme Medical Publishers, Inc.
2023-08-01
|
Series: | Indian Journal of Neurosurgery |
Subjects: | |
Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0042-1743265 |
Similar Items
-
Expression of IDH1, ATRX, p53 in Diagnosis of Gliomas as Per 2016 WHO Classification
by: Lokesh Kumar, et al.
Published: (2023-07-01) -
IDH-1, ATRX AND 1P19Q CO-DELETION IN DIFFUSE GLIOMAS
by: Rabia Javed, et al.
Published: (2020-04-01) -
The Role of ATRX in Glioma Biology
by: Pravanya Nandakumar, et al.
Published: (2017-09-01) -
Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery
by: Patrick J. Cimino, et al.
Published: (2017-05-01) -
Carbonic anhydrase related protein expression in astrocytomas and oligodendroglial tumors
by: Sini L. Karjalainen, et al.
Published: (2018-05-01)